
Bioorganic and Medicinal Chemistry Letters p. 1157 - 1162 (1998)
Update date:2022-08-05
Topics:
Campbell, David A.
Xiao, Xiao-Yi
Harris, David
Ida, Satoru
Mortezaei, Reza
Ngu, Khehyong
Shi, Lihong
Tien, David
Wang, Yongwen
Navre, Marc
Patel, Dinesh V.
Sharr, Michele A.
DiJoseph, John F.
Killar, Loran M.
Leone, Christina L.
Levin, Jeremy I.
Skotnicki, Jerauld S.
A novel series of matrix metalloproteinase (MMP) inhibitors is described. Incorporation of a terminal α-mercaptoketone or α- mercaptoalcohol in the zinc binding domain of a series of inhibitors led to compounds exhibiting low nanomolar activity against collagenase-1 (MMP-1), stromelysin (MMP-3), and gelatinase-B (MMP-9).
View MoreContact:+86-633-8332928
Address:No.1,Huanghai Yilu.Rizhao,Shandong
HANGZHOU FOREWIN PHARMA CO., LTD
Contact:+86-571-89053961
Address:hangzhou
ShanDong XinDa Chemical CO.,LTD(expird)
Contact:086-0311-87580543
Address:No.168, High Technology Development Zone Jinan Shandong China
Mollt Biochem Co., Ltd(expird)
Contact:+86-21-38682181
Address:shanghai ,china
Hubei Xiangxi Chemical Industry Co.,Ltd
Contact:+86-710-3454830
Address:No.7, Daqing East Road, Xiangfan City, Hubei Province, China
Doi:10.1111/cbdd.12319
(2014)Doi:10.1016/0022-328X(68)80072-5
(1968)Doi:10.1016/S0968-0896(96)00182-4
(1996)Doi:10.1039/a606575i
(1997)Doi:10.1021/jo962135m
(1997)Doi:10.1021/jo982154r
(1999)